Available and Emerging Treatment Options in FLT3-Mutant and IDH-Mutant AML

Amir Fathi, MD, provides expert insights and guidance on the best strategies to optimize treatment for patients with FLT3-mutant or IDH-mutant AML.
Amir Fathi, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.16 MB
Released: December 6, 2019

Acknowledgements

Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC
NCCN Logo

Karen Kanefield
Manager CE Accreditation & Program Operations
National Comprehensive Cancer Network
3025 Chemical Road, Suite 100
Plymouth Meeting, PA 19462

215-690-0239
215-690-0283 (Fax)
gianola@nccn.org
For Clinicians:
NCCN.org
For Patients:
NCCN.org/patients

Produced in collaboration with
NCCN Logo
Supported by educational grants from
Actinium Pharmaceuticals
Boston Biomedical, Inc.
Jazz Pharmaceuticals, Inc.
Pfizer Inc.

Related Content

Latest evidence on effective management of chronic lymphocytic leukemia (CLL) using BTK inhibitors in this video from Clinical Care Options (CCO)

Danielle Brander, MD Nicole Lamanna, MD Jeff P. Sharman, MD Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: September 16, 2020 Expired: September 15, 2021

Nicole Lamanna, MD, on modifying CLL treatment during COVID-19 pandemic, IVIg as COVID-19 prophylaxis, and the role of BTK inhibition, from CCO

Nicole Lamanna, MD Released: September 14, 2020

On-demand Webcast featuring experts’ review of evolving strategies for optimal treatment of patients with relapsed/refractory multiple myeloma in 2020

Shaji Kumar, MD
Program Director
Natalie S. Callander, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: September 14, 2020 Expired: September 13, 2021

Download this slideset from a CCO Live Meeting Series to review the latest evidence on selecting optimal management strategies for follicular lymphoma

John M. Burke, MD Peter Martin, MD Released: September 11, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?